Wadsworth S - Search Results

1

Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors.

Burnham B, Nass S, Kong E, Mattingly M, Woodcock D, Song A, Wadsworth S, Cheng SH, Scaria A, O'Riordan CR. Burnham B, et al. Among authors: wadsworth s. Hum Gene Ther Methods. 2015 Dec;26(6):228-42. doi: 10.1089/hgtb.2015.048. Epub 2015 Oct 15. Hum Gene Ther Methods. 2015. PMID: 26414997

2

Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice.

Siders WM, Shields J, Kaplan J, Lukason M, Woodworth L, Wadsworth S, Scaria A. Siders WM, et al. Among authors: wadsworth s. Hum Gene Ther. 2009 Jan;20(1):11-20. doi: 10.1089/hum.2008.055. Hum Gene Ther. 2009. PMID: 18828728 Free PMC article.

3

AAVS1-Targeted Plasmid Integration in AAV Producer Cell Lines.

Luo Y, Frederick A, Martin JM, Scaria A, Cheng SH, Armentano D, Wadsworth SC, Vincent KA. Luo Y, et al. Hum Gene Ther Methods. 2017 Jun;28(3):124-138. doi: 10.1089/hgtb.2016.158. Epub 2017 Apr 14. Hum Gene Ther Methods. 2017. PMID: 28504553

4

Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV).

O'Riordan CR, Lachapelle AL, Vincent KA, Wadsworth SC. O'Riordan CR, et al. Among authors: wadsworth sc. J Gene Med. 2000 Nov-Dec;2(6):444-54. doi: 10.1002/1521-2254(200011/12)2:6<444::AID-JGM132>3.0.CO;2-1. J Gene Med. 2000. PMID: 11199265

5

Aurintricarboxylic acid increases yield of HSV-1 vectors.

Pechan P, Ardinger J, Ketavarapu J, Rubin H, Wadsworth SC, Scaria A. Pechan P, et al. Mol Ther Methods Clin Dev. 2014 Feb 19;1:6. doi: 10.1038/mtm.2013.6. eCollection 2014. Mol Ther Methods Clin Dev. 2014. PMID: 26015945 Free PMC article.

6

Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates.

Lanciotti J, Song A, Doukas J, Sosnowski B, Pierce G, Gregory R, Wadsworth S, O'Riordan C. Lanciotti J, et al. Among authors: wadsworth s. Mol Ther. 2003 Jul;8(1):99-107. doi: 10.1016/s1525-0016(03)00139-4. Mol Ther. 2003. PMID: 12842433 Free article.

7

Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway.

Scaria A, St George JA, Gregory RJ, Noelle RJ, Wadsworth SC, Smith AE, Kaplan JM. Scaria A, et al. Among authors: wadsworth sc. Gene Ther. 1997 Jun;4(6):611-7. doi: 10.1038/sj.gt.3300431. Gene Ther. 1997. PMID: 9231078

8

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

O'Riordan CR, Lachapelle A, Delgado C, Parkes V, Wadsworth SC, Smith AE, Francis GE. O'Riordan CR, et al. Among authors: wadsworth sc. Hum Gene Ther. 1999 May 20;10(8):1349-58. doi: 10.1089/10430349950018021. Hum Gene Ther. 1999. PMID: 10365665

9

Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.

Romanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O'Riordan CR. Romanczuk H, et al. Among authors: wadsworth sc. Hum Gene Ther. 1999 Nov 1;10(16):2615-26. doi: 10.1089/10430349950016654. Hum Gene Ther. 1999. PMID: 10566889

10

Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.

Pechan P, Rubin H, Lukason M, Ardinger J, DuFresne E, Hauswirth WW, Wadsworth SC, Scaria A. Pechan P, et al. Among authors: wadsworth sc. Gene Ther. 2009 Jan;16(1):10-6. doi: 10.1038/gt.2008.115. Epub 2008 Jul 17. Gene Ther. 2009. PMID: 18633446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters